Krüppel-like factor 4 contributes to the pathogenesis of mantle cell lymphoma

References

• Cheah CY, Seymour JF, Wang ML. Mantle cell lymphoma. J Clin Oncol. 2016;34:1256–1269.
   PubMed Web of Science ®Google Scholar
• Jares P, Colomer D, Campo E. Molecular pathogenesis of mantle cell lymphoma. J Clin Invest. 2012;122:3416–3423.
   PubMed Web of Science ®Google Scholar
• Mathur R, Sehgal L, Braun FK, et al. Targeting Wnt pathway in mantle cell lymphoma-initiating cells. J Hematol Oncol. 2015;8:63.
   PubMed Web of Science ®Google Scholar
• Li PP, Feng LL, Chen N, et al. Metadherin contributes to the pathogenesis of chronic lymphocytic leukemia partially through Wnt/beta-catenin pathway. Med Oncol. 2015;32:479.
   PubMed Web of Science ®Google Scholar
• Wang F, Feng Y, Li P, et al. RASSF10 is an epigenetically inactivated tumor suppressor and independent prognostic factor in hepatocellular carcinoma. Oncotarget. 2016;7:4279–4297.
   PubMed Web of Science ®Google Scholar
• Wei D, Gong W, Kanai M, et al. Drastic down-regulation of Krüppel-like factor 4 expression is critical in human gastric cancer development and progression. Cancer Res. 2005;65:2746–2754.
   PubMed Web of Science ®Google Scholar
• Ma J, Yao Y, Wang P, et al. MiR-152 functions as a tumor suppressor in glioblastoma stem cells by targeting Krüppel-like factor 4. Cancer Lett. 2014;355:85–95.
   PubMed Web of Science ®Google Scholar
• Wei D, Kanai M, Huang S, et al. Emerging role of KLF4 in human gastrointestinal cancer. Carcinogenesis. 2006;27:23–31.
   PubMed Web of Science ®Google Scholar
• Qi H, Pei D. The magic of four: induction of pluripotent stem cells from somatic cells by Oct 4, Sox2, Myc and Klf4. Cell Res. 2007;17:578–580.
   PubMed Web of Science ®Google Scholar
• Tahmasebi S, Ghorbani M, Savage P, et al. Sumoylation of Krüppel-like factor 4 inhibits pluripotency induction but promotes adipocyte differentiation. J Biol Chem. 2013;288:12791–12804.
   PubMed Web of Science ®Google Scholar
• Karatas OF, Suer I, Yuceturk B, et al. The role of miR-145 in stem cell characteristics of human laryngeal squamous cell carcinoma Hep-2 cells. Tumour Biol. 2016;37:4183–4192.
   PubMed Web of Science ®Google Scholar
• Pandya AY, Talley LI, Frost AR, et al. Nuclear localization of KLF4 is associated with an aggressive phenotype in early-stage breast cancer. Clin Cancer Res. 2004;10:2709–2719.
   PubMed Web of Science ®Google Scholar
• Cordani N, Pozzi S, Martynova E, et al. Mutant p53 subverts p63 control over KLF4 expression in keratinocytes. Oncogene. 2011;30:922–932.
   PubMed Web of Science ®Google Scholar
• Chu Z, Niu B, Zhu H, et al. PRMT5 enhances generation of induced pluripotent stem cells from dairy goat embryonic fibroblasts via down-regulation of p53. Cell Prolif. 2015;48:29–38.
   PubMed Web of Science ®Google Scholar
• Hu W, Hofstetter WL, Li H, et al. Putative tumor-suppressive function of Kruppel-like factor 4 in primary lung carcinoma. Clin Cancer Res. 2009;15:5688–5695.
   PubMed Web of Science ®Google Scholar
• Nakahara Y, Northcott PA, Li M, et al. Genetic and epigenetic inactivation of Kruppel-like factor 4 in medulloblastoma. Neoplasia. 2010;12:20–27.
   PubMed Web of Science ®Google Scholar
• Ouyang H, Gore J, Deitz S, et al. microRNA-10b enhances pancreatic cancer cell invasion by suppressing TIP30 expression and promoting EGF and TGF-β actions. Oncogene. 2014;33:4664–4674.
   PubMed Web of Science ®Google Scholar
• Yang WT, Zheng PS. Promoter hypermethylation of KLF4 inactivates its tumor suppressor function in cervical carcinogenesis. PLoS ONE. 2014;9:e88827.
   PubMed Web of Science ®Google Scholar
• Sun H, Tang H, Xie D, et al. Kruppel-like factor 4 blocks hepatocellular carcinoma dedifferentiation and progression through activation of hepatocyte nuclear factor-6. Clin Cancer Res. 2016;22:502–512.
   PubMed Web of Science ®Google Scholar
• Guan H, Xie L, Leithauser F, et al. KLF4 is a tumor suppressor in B-cell non-Hodgkin lymphoma and in classic Hodgkin lymphoma. Blood. 2010;116:1469–1478.
   PubMed Web of Science ®Google Scholar
• Wang W, Corrigan-Cummins M, Hudson J, et al. MicroRNA profiling of follicular lymphoma identifies microRNAs related to cell proliferation and tumor response. Haematologica. 2012;97:586–594.
   PubMed Web of Science ®Google Scholar
• Gelebart P, Anand M, Armanious H, et al. Constitutive activation of the Wnt canonical pathway in mantle cell lymphoma. Blood. 2008;112:5171–5179.
   PubMed Web of Science ®Google Scholar
• Mohanty S, Mohanty A, Sandoval N, et al. Cyclin D1 depletion induces DNA damage in mantle cell lymphoma lines. Leuk Lymphoma. 2017;58:676–688.
   PubMed Web of Science ®Google Scholar
• Wang L, Shalek AK, Lawrence M, et al. Somatic mutation as a mechanism of Wnt/β-catenin pathway activation in CLL. Blood. 2014;124:1089–1098.
   PubMed Web of Science ®Google Scholar
• Hoffmeyer K, Raggioli A, Rudloff S, et al. Wnt/β-catenin signaling regulates telomerase in stem cells and cancer cells. Science. 2012;336:1549–1554.
   PubMed Web of Science ®Google Scholar
• Yu T, Chen X, Zhang W, et al. Regulation of the potential marker for intestinal cells, Bmi1, by β-catenin and the zinc finger protein KLF4: implications for colon cancer. J Biol Chem. 2012;287:3760–3768.
   PubMed Web of Science ®Google Scholar
• Zhang P, Chang WH, Fong B, et al. Regulation of induced pluripotent stem (iPS) cell induction by Wnt/β-catenin signaling. J Biol Chem. 2014;289:9221–9232.
   PubMed Web of Science ®Google Scholar
• Dreyling M, Thieblemont C, Gallamini A, et al. ESMO Consensus conferences: guidelines on malignant lymphoma. Part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma. Ann Oncol. 2013;24:857–877.
   PubMed Web of Science ®Google Scholar
• Vogt N, Dai B, Erdmann T, et al. The molecular pathogenesis of mantle cell lymphoma. Leuk Lymphoma. 2016. doi:10.1080/10428194.2016.1248965
   PubMed Web of Science ®Google Scholar
• Farrugia MK, Vanderbilt DB, Salkeni MA, et al. Kruppel-like pluripotency factors as modulators of cancer cell therapeutic responses. Cancer Res. 2016;76:1677–1682.
   PubMed Web of Science ®Google Scholar
• Gui X, Meng Z, McConnell YJ, et al. Differing expression profiles of Notch/enterocyte and Wnt/secretory lineage signallings are associated with morphological diversity of appendiceal tumours. J Clin Pathol. 2017;70:40–50.
   PubMed Web of Science ®Google Scholar
• Valencia-Hipomicronlito A, Hernandez-Atenogenes M, Vega GG, et al. Expression of KLF4 is a predictive marker for survival in pediatric Burkitt lymphoma. Leuk Lymphoma. 2014;55:1806–1814.
   PubMed Web of Science ®Google Scholar
• Kliman D, Barnett M, Broady R, et al. Comparison of a pediatric-inspired treatment protocol versus standard-intensity chemotherapy for young adults with standard-risk BCR-ABL negative acute lymphoblastic leukemia. Leuk Lymphoma. 2017;58:909–915.
   PubMed Web of Science ®Google Scholar
• Louissaint A, Jr, Schafernak KT, Geyer JT, et al. Pediatric-type nodal follicular lymphoma: a biologically distinct lymphoma with frequent MAPK pathway mutations. Blood. 2016;128:1093–1100.
   PubMed Web of Science ®Google Scholar
• Good KL, Tangye SG. Decreased expression of Kruppel-like factors in memory B cells induces the rapid response typical of secondary antibody responses. Proc Natl Acad Sci U S A. 2007;104:13420–13425.
   PubMed Web of Science ®Google Scholar
• Hu D, Gur M, Zhou Z, et al. Interplay between arginine methylation and ubiquitylation regulates KLF4-mediated genome stability and carcinogenesis. Nat Commun. 2015;6:8419.
   PubMed Web of Science ®Google Scholar
• Ehlers A, Oker E, Bentink S, et al. Histone acetylation and DNA demethylation of B cells result in a Hodgkin-like phenotype. Leukemia. 2008;22:835–841.
   PubMed Web of Science ®Google Scholar
• Kimura Y, Arakawa F, Kiyasu J, et al. The Wnt signaling pathway and mitotic regulators in the initiation and evolution of mantle cell lymphoma: gene expression analysis. Int J Oncol. 2013;43:457–468.
   PubMed Web of Science ®Google Scholar
• Evans PM, Chen X, Zhang W, et al. KLF4 interacts with beta-catenin/TCF4 and blocks p300/CBP recruitment by beta-catenin. Mol Cell Biol. 2010;30:372–381.
   PubMed Web of Science ®Google Scholar